• Study of S095035 and TNG462 in adults with advanced or metastatic solid tumors with MTAP deletion

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark France Germany Italy Spain

  • Study of alectinib, pemetrexed, carboplatin and cisplatin in patients with resectable stage I-III non-small cell lung cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Denmark France Italy The Netherlands +2

  • Study on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1
    Investigated drugs:
    Belgium Czechia Denmark Estonia Finland Germany +5

  • Study on the Long-Term Safety of Isatuximab for Adults with Multiple Myeloma Benefiting from Isatuximab Therapy

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Finland France Greece Italy Spain +1

  • Comparison of Sotorasib versus Docetaxel in Previously Treated Non-Small Cell Lung Cancer Patients with KRAS p.

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Greece Italy The Netherlands Poland +2

  • Study of venglustat tablets to reduce neuropathic and abdominal pain in patients aged 16 and older with Fabry disease who are untreated or haven’t received treatment for 6 months

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Austria Denmark Finland France Germany Greece +4

  • Study of Tarlatamab for Patients with Limited-Stage Small-Cell Lung Cancer After Chemoradiotherapy

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Bulgaria France Germany Greece +6

  • Study of Sotorasib Alone and Combined with Pembrolizumab in Adult Patients with Advanced Solid Tumors Having KRAS p.

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium France Greece Hungary Portugal +2

  • Study comparing tarlatamab with topotecan in patients with relapsed small cell lung cancer after first-line chemotherapy

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Austria Belgium Czechia Denmark France Germany +9

  • A study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.

    Not recruiting

    3 1
    Bulgaria Czechia Germany Hungary Poland Romania +2

powered by